{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:29:12Z","timestamp":1790490552039,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T00:00:00Z","timestamp":1530576000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Clinical Cooperation Group \u201cPersonalized Radiotherapy in Head and Neck Cancer\u201d"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13014-018-1067-1","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T08:39:06Z","timestamp":1530607146000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck \u2013 clinical results from the cohort of the clinical cooperation group \u201cPersonalized Radiotherapy in Head and Neck Cancer\u201d"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0506-4519","authenticated-orcid":false,"given":"Cornelius","family":"Maihoefer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Sch\u00fcttrumpf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Macht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Pflugradt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludmila","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Woischke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Walch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Baumeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kirchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horst","family":"Zitzelsberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Belka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Ganswindt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,3]]},"reference":[{"key":"1067_CR1","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1056\/NEJMoa032646","volume":"350","author":"JS Cooper","year":"2004","unstructured":"Cooper JS, Pajak TFTF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350:1937\u201344.","journal-title":"N Engl J Med"},{"key":"1067_CR2","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1056\/NEJMoa032641","volume":"350","author":"J Bernier","year":"2004","unstructured":"Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lef\u00e8bvre J-L, Greiner RH, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350:1945\u201352.","journal-title":"N Engl J Med"},{"key":"1067_CR3","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/cncr.23206","volume":"112","author":"A Lavaf","year":"2008","unstructured":"Lavaf A, Genden EM, Cesaretti JA, Packer S, Kao J. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma. Cancer. 2008;112:535\u201343.","journal-title":"Cancer"},{"key":"1067_CR4","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.ijrobp.2007.09.058","volume":"71","author":"J Kao","year":"2008","unstructured":"Kao J, Lavaf A, Teng MMS, Huang D, Genden EM. Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage. Int J Radiat Oncol Biol Phys. 2008;71:362\u201370.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1067_CR5","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00066-011-2262-2","volume":"187","author":"D Rades","year":"2011","unstructured":"Rades D, Meyners T, Kazic N, Bajrovic A, Rudat V, Schild SE. Comparison of radiochemotherapy alone to surgery plus radio(chemo)therapy for non-metastatic stage III\/IV squamous cell carcinoma of the head and neck: a matched-pair analysis. Strahlenther Onkol. 2011;187:541\u20137.","journal-title":"Strahlenther Onkol"},{"key":"1067_CR6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0360-3016(97)00817-1","volume":"40","author":"RE Lundahl","year":"1998","unstructured":"Lundahl RE, Foote RL, Bonner JA, Suman VJ, Lewis JE, Kasperbauer JL, et al. Combined neck dissection and postoperative radiation therapy in the management of the high-risk neck: a matched-pair analysis. Int J Radiat Oncol. 1998;40:529\u201334.","journal-title":"Int J Radiat Oncol"},{"key":"1067_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13014-015-0490-9","volume":"10","author":"C-C Chen","year":"2015","unstructured":"Chen C-C, Lin J-C, Chen K-W. Lymph node ratio as a prognostic factor in head and neck cancer patients. Radiat Oncol. 2015;10:181.","journal-title":"Radiat Oncol"},{"key":"1067_CR8","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/hed.20279","volume":"27","author":"J Bernier","year":"2005","unstructured":"Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck. 2005;27:843\u201350.","journal-title":"Head Neck"},{"key":"1067_CR9","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.1200\/jco.2006.24.18_suppl.5507","volume":"24","author":"R Fietkau","year":"2006","unstructured":"Fietkau R, Lautenschl\u00e4ger C, Sauer R. Postoperative concurrent radiochemotherapy versus radiotherapy in high-risk SCCA of the head and neck: results of the German phase III trial ARO 96-3 (abstract only). J Clin Oncol. 2006;24:5507.","journal-title":"J Clin Oncol"},{"key":"1067_CR10","doi-asserted-by":"publisher","first-page":"e292","DOI":"10.1016\/S1470-2045(12)70237-1","volume":"13","author":"V Gr\u00e9goire","year":"2012","unstructured":"Gr\u00e9goire V, Jeraj R, Lee JA, O\u2019Sullivan B. Radiotherapy for head and neck tumours in 2012 and beyond: conformal, tailored, and adaptive? Lancet Oncol. 2012;13:e292\u2013300. Elsevier Ltd","journal-title":"Lancet Oncol"},{"key":"1067_CR11","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s00066-011-1139-8","volume":"187","author":"D Rades","year":"2011","unstructured":"Rades D, Seibold ND, Gebhard MP, Noack F, Schild SE, Thorns C. Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN). Strahlenther Onkol. 2011;187:626\u201332.","journal-title":"Strahlenther Onkol"},{"key":"1067_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa0912217","volume":"363","author":"K Ang","year":"2010","unstructured":"Ang K, Harris J, Wheeler R. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24\u201335.","journal-title":"N Engl J Med"},{"key":"1067_CR13","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/jnci\/djn011","volume":"100","author":"C Fakhry","year":"2008","unstructured":"Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"1067_CR14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.radonc.2014.11.011","volume":"113","author":"F Lohaus","year":"2014","unstructured":"Lohaus F, Linge A, Tinhofer I, Budach V, Gkika E, Stuschke M, et al. HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). Radiother Oncol. 2014;113:317\u201323. Elsevier Ireland Ltd","journal-title":"Radiother Oncol"},{"key":"1067_CR15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00066-014-0753-7","volume":"191","author":"G Heiduschka","year":"2015","unstructured":"Heiduschka G, Grah A, Oberndorfer F, Kadletz L, Altorjai G, Kornek G, et al. Improved survival in HPV\/p16-positive oropharyngeal cancer patients treated with postoperative radiotherapy. Strahlenther Onkol. 2015;191:209\u201316.","journal-title":"Strahlenther Onkol."},{"key":"1067_CR16","doi-asserted-by":"crossref","unstructured":"Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials. 1996;17:343\u20136.","DOI":"10.1016\/0197-2456(96)00075-X"},{"key":"1067_CR17","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.ijrobp.2012.05.008","volume":"84","author":"JS Cooper","year":"2012","unstructured":"Cooper JS, Zhang Q, Pajak TF, Forastiere AA, Jacobs J, Saxman SB, et al. Long-term follow-up of the RTOG 9501\/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2012;84:1198\u2013205. Elsevier Inc","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1067_CR18","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1200\/JCO.2013.53.9163","volume":"32","author":"PM Harari","year":"2014","unstructured":"Harari PM, Harris J, Kies MS, Myers JN, Jordan RC, Gillison ML, et al. Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: radiation therapy oncology group RTOG-0234. J Clin Oncol. 2014;32:2486\u201395.","journal-title":"J Clin Oncol"},{"key":"1067_CR19","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/S1470-2045(15)00560-4","volume":"17","author":"B O\u2019Sullivan","year":"2016","unstructured":"O\u2019Sullivan B, Huang SH, Su J, Garden AS, Sturgis EM, Dahlstrom K, et al. Development and validation of a staging system for HPV-related oropharyngeal cancer by the international collaboration on oropharyngeal cancer network for staging (ICON-S): a multicentre cohort study. Lancet Oncol. 2016;17:440\u201351. Elsevier Ltd","journal-title":"Lancet Oncol"},{"key":"1067_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.radonc.2017.12.007","volume":"127","author":"A Linge","year":"2017","unstructured":"Linge A, Sch\u00f6tz U, L\u00f6ck S, Lohaus F, von Neubeck C, Gudziol V, et al. Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC. Radiother Oncol. 2017;127:27\u201335. Elsevier BV","journal-title":"Radiother Oncol"},{"key":"1067_CR21","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1093\/jjco\/hyw099","volume":"46","author":"J Lee","year":"2016","unstructured":"Lee J, Chang JS, Kwon HJ, Kim SH, Shin SJ, Keum KC. Impact of p16 expression in oropharyngeal cancer in the postoperative setting: the necessity of re-evaluating traditional risk stratification. Jpn J Clin Oncol. 2016;46:911\u20138.","journal-title":"Jpn J Clin Oncol"},{"key":"1067_CR22","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1002\/hed.24486","volume":"38","author":"RI Chin","year":"2016","unstructured":"Chin RI, Spencer CR, DeWees T, Hwang MY, Patel P, Sinha P, et al. Reevaluation of postoperative radiation dose in the management of human papillomavirus-positive oropharyngeal cancer. Head Neck. 2016;38:1643\u20139.","journal-title":"Head Neck."},{"key":"1067_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.semradonc.2017.08.001","volume":"28","author":"BS Chera","year":"2018","unstructured":"Chera BS, Amdur RJ. Current status and future directions of treatment deintensification in human papilloma virus-associated oropharyngeal squamous cell carcinoma. Semin Radiat Oncol. 2018;28:27\u201334. Elsevier","journal-title":"Semin Radiat Oncol"},{"key":"1067_CR24","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/hed.24974","volume":"40","author":"JD Cramer","year":"2018","unstructured":"Cramer JD, Hicks KE, Rademaker AW, Patel UA, Samant S. Validation of the eighth edition American Joint Committee on Cancer staging system for human papillomavirus-associated oropharyngeal cancer. Head Neck. 2018;40:457\u201366.","journal-title":"Head Neck."},{"key":"1067_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2017.00129","volume":"7","author":"N W\u00fcrdemann","year":"2017","unstructured":"W\u00fcrdemann N, Wagner S, Sharma SJ, Prigge E-S, Reuschenbach M, Gattenl\u00f6hner S, et al. Prognostic impact of AJCC\/UICC 8th edition new staging rules in oropharyngeal squamous cell carcinoma. Front Oncol. 2017;7:1\u201310.","journal-title":"Front Oncol"},{"key":"1067_CR26","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1186\/s12885-015-1598-x","volume":"15","author":"W Owadally","year":"2015","unstructured":"Owadally W, Hurt C, Timmins H, Parsons E, Townsend S, Patterson J, et al. PATHOS: a phase II\/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for human papillomavirus (HPV) positive oropharyngeal cancer. BMC Cancer. 2015;15:602.","journal-title":"BMC Cancer"},{"key":"1067_CR27","unstructured":"Ferris R. Transoral surgery followed by low-dose or standard-dose radiation therapy with or without chemotherapy in treating patients with HPV positive stage III-IVA oropharyngeal cancer - Full Text View - ClinicalTrials.gov [Internet]. p. NCT01898494. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT01898494 . [Cited 29 May 2018]."},{"key":"1067_CR28","unstructured":"Ma DJ. Evaluation of de-escalated adjuvant radiation therapy for human papillomavirus (HPV)-associated oropharynx cancer [Internet]. ClinicalTrials.gov. 2016. p. NCT02908477. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02908477 . [Cited 16 Feb 2018]."},{"key":"1067_CR29","unstructured":"Krause M. De-escalation of adjuvant radio (Chemo) therapy for HPV-positive head-neck squamous cell carcinomas - Full Text View - ClinicalTrials.gov [Internet]. 2018. p. NCT03396718. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03396718 . [Cited 12 Feb 2018]."},{"key":"1067_CR30","unstructured":"Post operative adjuvant therapy de-intensification trial for human papillomavirus-related, p16+ oropharynx cancer (ADEPT) [Internet]. ClinicalTrials.gov. 2012. p. NCT01687413. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01687413 . [Cited 15 May 2017]."},{"key":"1067_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13014-015-0561-y","volume":"10","author":"M Hoffmann","year":"2015","unstructured":"Hoffmann M, Saleh-Ebrahimi L, Zwicker F, Haering P, Schwahofer A, Debus J, et al. Long term results of postoperative intensity-modulated radiation therapy (IMRT) in the treatment of squamous cell carcinoma (SCC) located in the oropharynx or oral cavity. Radiat Oncol. 2015;10:1\u201313.","journal-title":"Radiat Oncol"},{"key":"1067_CR32","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.oraloncology.2016.10.003","volume":"62","author":"M Mermod","year":"2016","unstructured":"Mermod M, Tolstonog G, Simon C, Monnier Y. Extracapsular spread in head and neck squamous cell carcinoma: a systematic review and meta-analysis. Oral Oncol. 2016;62:60\u201371. Elsevier Ltd","journal-title":"Oral Oncol"},{"key":"1067_CR33","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1634\/theoncologist.2016-0318","volume":"22","author":"JM Moskovitz","year":"2017","unstructured":"Moskovitz JM, Moy J, Seiwert TY, Ferris RL. Immunotherapy for head and neck squamous cell carcinoma: a review of current and emerging therapeutic options. Oncologist. 2017;22:680\u201393.","journal-title":"Oncologist"},{"key":"1067_CR34","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","volume":"375","author":"RL Ferris","year":"2016","unstructured":"Ferris RL, Blumenschein G, Fayette J, Guigay J, Colevas AD, Licitra L, et al. Nivolumab for recurrent squamous-cell carcinoma of the head and neck. N Engl J Med. 2016;375:1856\u201367.","journal-title":"N Engl J Med"},{"key":"1067_CR35","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/bjc.2015.111","volume":"113","author":"I Summerer","year":"2015","unstructured":"Summerer I, Unger K, Braselmann H, Schuettrumpf L, Maihoefer C, Baumeister P, et al. Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients. Br J Cancer. 2015;113:76\u201382. Nature Publishing Group","journal-title":"Br J Cancer"},{"key":"1067_CR36","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1002\/ijc.31213","volume":"142","author":"S Stangl","year":"2018","unstructured":"Stangl S, Tontcheva N, Sievert W, Shevtsov M, Niu M, Schmid TE, et al. Heat shock protein 70 and tumor-infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group. Int J Cancer. 2018;142:1911\u201325.","journal-title":"Int J Cancer"},{"key":"1067_CR37","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s00066-016-0999-3","volume":"192","author":"P Ghadjar","year":"2016","unstructured":"Ghadjar P, P\u00f6ttgen C, Joos D, Hayoz S, Baumann M, Bodis S, et al. Haemoglobin and creatinine values as prognostic factors for outcome of concurrent radiochemotherapy in locally advanced head and neck cancers. Strahlenther Onkol. 2016;192:552\u201360.","journal-title":"Strahlenther Onkol."},{"key":"1067_CR38","doi-asserted-by":"crossref","unstructured":"Schmidt S, Linge A, Zwanenburg A, Leger S, Lohaus F, Krenn C, et al. Development and validation of a gene signature for patients with head and neck carcinomas treated by postoperative radio(chemo)therapy. Clin Cancer Res. 2018;24:1364\u201374.","DOI":"10.1158\/1078-0432.CCR-17-2345"},{"key":"1067_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejca.2017.02.018","volume":"77","author":"AK Hess","year":"2017","unstructured":"Hess AK, M\u00fcer A, Mairinger FD, Weichert W, Stenzinger A, Hummel M, et al. MiR-200b and miR-155 as predictive biomarkers for the efficacy of chemoradiation in locally advanced head and neck squamous cell carcinoma. Eur J Cancer. 2017;77:3\u201312.","journal-title":"Eur J Cancer"},{"key":"1067_CR40","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejca.2016.01.003","volume":"57","author":"I Tinhofer","year":"2016","unstructured":"Tinhofer I, Budach V, Saki M, Konschak R, Niehr F, J\u00f6hrens K, et al. Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation. Eur J Cancer. 2016;57:78\u201386.","journal-title":"Eur J Cancer"},{"key":"1067_CR41","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/ijc.30770","volume":"141","author":"P Balermpas","year":"2017","unstructured":"Balermpas P, R\u00f6del F, Krause M, Linge A, Lohaus F, Baumann M, et al. The PD-1\/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: a multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). Int J Cancer. 2017;141:594\u2013603.","journal-title":"Int J Cancer"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1067-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-018-1067-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1067-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T23:54:35Z","timestamp":1604534075000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-018-1067-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,3]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1067"],"URL":"https:\/\/doi.org\/10.1186\/s13014-018-1067-1","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,3]]},"assertion":[{"value":"1 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"For data analysis and the retrospective analysis of HPV p16 in some of the patients an ethics approval and consent was obtained (Ethics committee of the medical faculty of the LMU Munich. 448\u201313; 459\u201313; 17\u2013116).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"123"}}